BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34079521)

  • 1. Predictor Analysis in Radiofrequency Ablation of Benign Thyroid Nodules: A Single Center Experience.
    Bisceglia A; Rossetto R; Garberoglio S; Franzin A; Cerato A; Maletta F; Papotti MG; Ghigo E; Pagano L; Maccario M; Garberoglio R
    Front Endocrinol (Lausanne); 2021; 12():638880. PubMed ID: 34079521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation for Benign Nonfunctional Thyroid Nodules in Children: A Retrospective Study of 62 Patients with Over Four Years of Follow-Up.
    Li L; Qiu X
    Thyroid; 2022 May; 32(5):525-535. PubMed ID: 34915754
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of radiofrequency ablation for benign thyroid nodules in patients with previous thyroid lobectomy.
    Yan L; Zhang M; Xie F; Ma J; Xiao J; Luo Y
    BMC Med Imaging; 2021 Mar; 21(1):47. PubMed ID: 33706713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ultrasound parameters of benign thyroid nodules on radiofrequency ablation efficacy.
    Motaghed Z; Chegeni H; Mosadeghkhah A; Azimi Aval M; Gerami R; Ebrahiminik H
    BMC Med Imaging; 2023 Jun; 23(1):85. PubMed ID: 37337132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid benign thyroid nodules (>10 ml): a retrospective study on the efficacy and safety of sonographically guided ethanol ablation combined with radiofrequency ablation.
    Zhu Y; Zhang M; Jin Z; Tian X; Zhang Y; Xie F; Song Q; Yan L; Jiang B; Tang J; Luo Y
    Int J Hyperthermia; 2020; 37(1):157-167. PubMed ID: 32024398
    [No Abstract]   [Full Text] [Related]  

  • 6. Differences in the ultrasonographic appearance of thyroid nodules after radiofrequency ablation.
    Wu MH; Chen KY; Chen A; Chen CN
    Clin Endocrinol (Oxf); 2021 Sep; 95(3):489-497. PubMed ID: 33938024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful radiofrequency ablation strategies for benign thyroid nodules.
    Lee GM; You JY; Kim HY; Chai YJ; Kim HK; Dionigi G; Tufano RP
    Endocrine; 2019 May; 64(2):316-321. PubMed ID: 30569260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules: 12-Month Results of a Randomized Trial (LARA II Study).
    Cesareo R; Manfrini S; Pasqualini V; Ambrogi C; Sanson G; Gallo A; Pozzilli P; Pedone C; Crescenzi A; Palermo A
    J Clin Endocrinol Metab; 2021 May; 106(6):1692-1701. PubMed ID: 33608728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT-based quantitative evaluation of the efficacy after radiofrequency ablation in patients with benign thyroid nodules.
    Choi Y; Jung SL; Jang J; Shin NY; Ahn KJ; Kim BS
    Int J Hyperthermia; 2020; 37(1):742-748. PubMed ID: 33480816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volume reduction rate of radiofrequency ablation in ≤ 2 cm Bethesda IV thyroid nodules.
    Dong Y; Zhan W; Zhou J; Li N; Liu Z; Xia S; Ni X; Liu J; Zhang J; Xu S; Yang Z; Hua Q
    Eur Radiol; 2024 Mar; 34(3):1597-1604. PubMed ID: 37665388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency Ablation for Benign Thyroid Nodules: 1-Year Follow-Up in 184 Patients.
    Vuong NL; Dinh LQ; Bang HT; Thuy TTM; Bac NH; Vy TT
    World J Surg; 2019 Oct; 43(10):2447-2453. PubMed ID: 31165252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter-observer reliability in ultrasound measurement of benign thyroid nodules in the follow-up of radiofrequency ablation: a retrospective study.
    Yan L; Luo Y; Song Q; Li N; Xiao J; Zhang Y; Zhu Y
    Int J Hyperthermia; 2020 Nov; 37(1):1336-1344. PubMed ID: 33251890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anhydrous Ethanol Improves Efficiency of Radiofrequency Ablation for the Treatment of Benign Thyroid Nodules:A Prospective Randomized Controlled Trial].
    Zhu Y; Jin Z; Zhang Y; Jiang B; Yan L; Tian X; Zhang M; Luo Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Jun; 42(3):331-337. PubMed ID: 32616128
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors associated with initial incomplete ablation for benign thyroid nodules after radiofrequency ablation: First results of CEUS evaluation.
    Zhao CK; Xu HX; Lu F; Sun LP; He YP; Guo LH; Li XL; Bo XW; Yue WW
    Clin Hemorheol Microcirc; 2017; 65(4):393-405. PubMed ID: 27983547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Learning curve for radiofrequency ablation of benign thyroid nodules.
    Russ G; Ben Hamou A; Poirée S; Ghander C; Ménégaux F; Leenhardt L; Buffet C
    Int J Hyperthermia; 2021; 38(1):55-64. PubMed ID: 33491515
    [No Abstract]   [Full Text] [Related]  

  • 16. Monopolar Radiofrequency Ablation of Thyroid Nodules: A Prospective Austrian Single-Center Study.
    Dobnig H; Amrein K
    Thyroid; 2018 Apr; 28(4):472-480. PubMed ID: 29490593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study.
    Yan L; Luo Y; Zhang M; Xiao J
    Int J Hyperthermia; 2020; 37(1):777-785. PubMed ID: 32619366
    [No Abstract]   [Full Text] [Related]  

  • 18. Determining an energy threshold for optimal volume reduction of benign thyroid nodules treated by radiofrequency ablation.
    Deandrea M; Trimboli P; Mormile A; Cont AT; Milan L; Buffet C; Giovanella L; Limone PP; Poirée S; Leenhardt L; Russ G
    Eur Radiol; 2021 Jul; 31(7):5189-5197. PubMed ID: 33409792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer-Analyzed Ultrasound Predictors of the Treatment Efficacy of Radiofrequency Ablation for Benign Thyroid Nodules.
    Kuo CY; Wu MH; Ko WC; Cheng SP
    World J Surg; 2022 Jan; 46(1):112-120. PubMed ID: 34608544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Perspective for Predicting the Therapeutic Success of RFA in Solid BTNs: Quantitative Initial RFA Ratio by Contrast-Enhanced Ultrasound.
    Zhu Y; Jiao Z; Zhu L; Xie F; Song Q; Yan L; Luo Y; Zhang M
    Front Endocrinol (Lausanne); 2022; 13():904459. PubMed ID: 35774147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.